Neurotoxic aspects of porphyrinopathies: Lead and succinylacetone
- 16 December 1982
- journal article
- research article
- Published by Elsevier in Environmental Research
- Vol. 29 (2) , 459-471
- https://doi.org/10.1016/0013-9351(82)90046-9
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- δ-Aminolaevulinic acid is a potent agonist for GABA autoreceptorsNature, 1979
- Inhibition of the evoked release of acetylcholine by the porphyrin precursor δ‐aminolevulinic acidAnnals of Neurology, 1979
- Lead and Polychlorinated Biphenyls: Effects on Heme and Drug MetabolismDrug Metabolism Reviews, 1979
- THE NEUROLOGICAL MANIFESTATIONS OF PORPHYRIAMedicine, 1977
- Dose-effect and dose-response relationships for lead in childrenThe Journal of Pediatrics, 1975
- Drug metabolism in normal children, lead‐poisoned children, and normal adultsClinical Pharmacology & Therapeutics, 1975
- On the nature of the peripheral nerve lesions associated with acute intermittent porphyriaJournal of Neurology, Neurosurgery & Psychiatry, 1965
- Industrially Acquired PorphyriaArchives of Dermatology, 1964
- Disturbances in the biosynthesis of heme in lead intoxicationThe Journal of Pediatrics, 1964
- Control of Porphyrin Biosynthesis through a Negative-Feedback Mechanism. STUDIES WITH PREPARATIONS OF δ-AMINOLAEVULATE SYNTHETASE AND δ-AMINOLAEVULATE DEHYDRATASE FROM RHODOPSEUDOMONAS SPHEROIDESBiochemical Journal, 1963